SEMINAR

Machine learning in medical diagnostic and drug discovery

Speaker

Minh Duc Cao

Working
Gritstone Oncology
Timeline
Thu, Dec 19 2019 - 10:00 am (GMT + 7)
About Speaker

Dr Minh Duc Cao is a principal machine learning scientist at Gritstone Oncology Inc where he leads a team developing deep learning models for designing personalized cancer therapy. He previously was a senior bioinformatics scientist at 4Catalyzer, a startup founded by technology pioneer Professor Jonathon Rothberg that aims to transform medicine with devices, deep learning and the cloud computing. Dr. Cao completed his PhD in Bioinformatics at Monash University where he applied advanced statistics and information theory into modelling genomics data. During this time, he developed state‐of‐the‐arts genomic analysis methods, including data compression, sequence alignment and phylogenetics analysis. He then carried out his postdoctoral research and worked as a research scientist at the University of Queensland, applying machine learning and sequencing technologies to investigate genomics variation that underlies human diseases. He has been contributing to the development of third generation sequencing technology by developing novel methodologies to improve the quality of sequencing data and to translate sequencing technologies into practice. Dr. Cao has also consulted on deployment of high performance computing facilities for genomics research.

Abstract

Advances on biotechnology have profoundly transformed science and medicine and been making impacts in saving human lives over the last 15 years in ways never seen before. This has since generated enormous amounts of data and is projected to be the biggest data source on the planet by 2025. The sheer volume of life science data, together with their noisiness present a big challenge to the making sense of the data. The era also coincides with the age of big data where advanced analytics are widely developed and adopted in industry but are hardly utilized for biological data. In this seminar, I will share my own experience in applying machine learning into genomics and proteomics data for diagnostic and drug discovery. I show that not only are these techniques more effective than classical approaches, but they also help to reduce cost and time of sequencing projects, and hence contribute to translating sequencing technologies into practice.

Related seminars

Representation Learning with Graph Autoencoders and Applications to Music Recommendation
Fri, Jul 26 2024 - 10:00 am (GMT + 7)

Trieu Trinh

Google Deepmind

AlphaGeometry: Solving IMO Geometry without Human Demonstrations
Fri, Jul 5 2024 - 10:00 am (GMT + 7)

Tat-Jun (TJ) Chin

Adelaide University

Quantum Computing in Computer Vision: A Case Study in Robust Geometric Optimisation
Fri, Jun 7 2024 - 11:00 am (GMT + 7)

Fernando De la Torre

Carnegie Mellon University

Human Sensing for AR/VR
Wed, Apr 24 2024 - 07:00 am (GMT + 7)